je.st
news
Home
›
Life Technologies Announces Regulatory Approval of Its 3500 Dx Series Genetic Analyzers in Canada
Life Technologies Announces Regulatory Approval of Its 3500 Dx Series Genetic Analyzers in Canada
2013-05-20 06:00:00| Industrial Newsroom - All News for Today
CARLSBAD, Calif. -- Life Technologies Corporation (NASDAQ:LIFE) today announced that its Applied Biosystems™ 3500 Dx /3500 xL Dx Genetic Analyzers CS2 have been approved by Health Canada for diagnostic use. The development marks a major extension of Life Technologies' capabilities to serve the clinical end market in North America with Sanger-based solutions.<br /> <br /> The Applied Biosystems™ 3500 Dx Series Genetic Analyzers deliver high quality performance, higher throughput and ...This story is related to the following:Test and Measuring InstrumentsSearch for suppliers of: Diagnostic Instruments |
Tags: life
canada
series
technologies
Category:Industrial Goods and Services
Latest from this category |
All news |
||||||||||||||||||||||
|
|